T-Cell Leukemia Translocation Altered (TCTA) Peptide
TCTA
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939500
$398.38
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 16 to 22 Business Days
Quick Overview for T-Cell Leukemia Translocation Altered (TCTA) Peptide (ABIN939500)
Target
TCTA
(T-Cell Leukemia Translocation Altered (TCTA))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- IQLAWGFYGN TVTGLYHRPG LGGQNGSTPD GSTHFPSWEM AANEPLKTHR
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TCTA antibody,
Alternative Names: TCTA control peptide, TCTA antibody Blocking Peptide, Anti-TCTA Blocking Peptide, T-Cell Leukemia Translocation Altered Gene Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- TCTA (T-Cell Leukemia Translocation Altered (TCTA))
-
Background
- A chromosomal aberration, translocation t(1,3)(p34,p21), involving TCTA is associated with T-cell acute lymphoblastic leukemia (T-ALL).
-
Molecular Weight
- 11 kDa
Target
-
You are here:
